Skip to main content

Table 1 Studies with estimates of ART uptake in the context of integrated HIV/TB treatment among adults in SSA

From: Barriers to and enablers of uptake of antiretroviral therapy in integrated HIV and tuberculosis treatment programmes in sub-Saharan Africa: a systematic review and meta-analysis

 

Author, year

Study setting

Study design

HIV/TB co-infected

Participants with required data

Uptake (%)

1

Burnett, 2018

Rural Uganda

Cross-sectional

179

103

47.7

2

Ferroussier, 2013

Rural and urban Benin

Retrospective cohort

1255

1111

42

3

Gasana, 2008

Rural Rwanda

Prospective cohort

125

125

43.2

4

Harris, 2008

Urban Zambia

Prospective cohort

1006

1006

59

5

Shaffer, 2011

Rural Kenya

Secondary analyses of retrospective cohort data

1911

1911

35.8

6

Simieneh, 2017

Urban Ethiopia

Cross-sectional

246

246

31.7

7

Takarinda, 2012

Rural and urban Zimbabwe

Retrospective cohort study

2655

2655

42

8

Tweya, 2014 (before implementation of

2011 Malawi national ART/PMTCT guidelines)

Urban Malawi

Retrospective cohort

377

377

70

9

Tweya 2014 (after implementation of 2011 Malawi national ART/PMTCT guidelines)

Urban Malawi

Retrospective cohort

308

308

78

10

Van Rie, 2014

Urban DRC

Prospective cohort study

513

513

69

11

Kumwenda, 2011

Rural and urban Malawi

Retrospective cohort

996

996

38.1

12

Pepper, 2011

Urban slum, South Africa

Secondary analysis of prospective cohort data

100

100

66

13

Ndagijimana, 2015 (Setting of Kicukiro)

Urban Rwanda

Retrospective cohort

352

352

71

14

Ndagijimana, 2015 (Setting of Rulindo)

Rural Rwanda

Retrospective cohort

60

60

93.8

15

Njozing, 2010

Urban and rural Cameroon

Retrospective cohort

1473

1220

50.3

16

Patel, 2014

Urban DRC

Prospective cohort

599

492

82.5

17

Hermans, 2012

Urban Uganda

Retrospective cohort

366

228

57

18

Huerga, 2010 (short-term after integration)

Rural Kenya

Retrospective cohort

437

325

46.2

19

Huerga, 2010 (medium term after integration)

Rural Kenya

Retrospective cohort

477

332

41.3

20

Kanyerere, 2012

Urban Malawi

Retrospective cohort

1190

1190

57.8

21

Ledibane, 2015

Rural and urban South Africa

Cross-sectional

2761

2761

35.9

22

Owiti, 2015

Rural Kenya

Retrospective cohort

323

323

60.7

23

Pathmanathan, 2018

Rural and urban Swaziland

Retrospective cohort

466

277

98.9

24

Ansa, 2014

Urban Ghana

Prospective and retrospective cohort

132

79

59.5

25

Van Lettow, 2011 (before policy to start ART as early as 2 weeks after commencing treatment for active TB

Urban Malawi

Prospective cohort study

1111

1111

21.2

26

Van Lettow, 2011 (after policy to start ART as early as 2 weeks after commencing treatment for active TB)

Urban Malawi

Prospective cohort study

1072

1072

28.5

27

Phiri, 2011 (ART started during

first 2 months of

TB treatment: 2008 reporting period)

Urban Malawi

Case study approach

1219

1219

17

28

Phiri, 2011 (ART started during

first 2 months of

TB treatment: 2009 reporting period)

Urban Malawi

Case study approach

1138

1138

38

    

22,847

21,630

 
  1. ART antiretroviral therapy, PMTCT prevention of maternal-to-child transmission, SSA sub-Saharan Africa